Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Sclerosis

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, I; Fukuchi, K; Hayashida, K; Imakita, S; Ishida, Y; Kume, N; Kumita, S; Shimotsu, Y; Takamiya, M; Toba, M1

Other Studies

1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Sclerosis

ArticleYear
Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia.
    Annals of nuclear medicine, 1998, Volume: 12, Issue:3

    Topics: Bone Density; Facial Bones; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Glucose; Humans; Hyperplasia; Middle Aged; Radiopharmaceuticals; Sclerosis; Skull; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

1998